Stopped: This study has been transferred to the Human Research Ethics Committee of St Vincent's Hospital Melbourne.
This study investigates a novel, non-invasive imaging technique called hyperspectral retinal imaging to improve the identification and characterisation of retinal and choroidal structures in both healthy and diseased eyes. Hyperspectral imaging captures retinal images across multiple wavelengths of light, generating detailed spectral information that may reveal biological and structural features not visible with conventional retinal photography. Approximately 1000 participants will undergo retinal imaging at specialist eye clinics in Melbourne, Australia. The study aims to determine whether hyperspectral imaging can detect spectral signatures associated with retinal and optic nerve diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration, and whether these signatures correlate with disease severity.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Optimisation and characterisation of hyperspectral retinal imaging spectral signatures in normal and diseased eyes
Timeframe: Single study visit (approximately 60 minutes), with additional optional follow-up imaging visits for longitudinal data collection where applicable.